CVS Health Corporation (NYSE: CVS) reported first quarter 2023 earnings results today. Total revenues increased 11% year-over-year to $85.3 billion. Net income
CVS Health Corp. (CVS) Q1 2023 Earnings: Key financials and quarterly highlights
Categories
retail pharmacy
Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform. It is
Rite Aid Corporation (RAD) Q4 2023 net loss narrows
Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.
The future looks bright for UnitedHealth Group (UNH). Is the stock a buy?
Health insurance companies have been witnessing a decline in claims lately as non-urgent medical procedures are being deferred due to high inflation
CVS Health Corporation (CVS) bets big on primary care. What future holds
Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while also aligning
WBA Earnings: All you need to know about Walgreens Boots Alliance’s Q2 2023 earnings results
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2023 earnings results today. Sales increased 3.3% year-over-year to $34.9 billion. Net earnings
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's
CVS Earnings: CVS Health Q4 2022 profit, revenue increase
CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase in adjusted
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings declined. Unadjusted
Should you buy CVS Health (CVS) stock before Q4 earnings?
CVS Health Corporation (NYSE: CVS), the largest retail pharmacy chain, is on a mission to make quality healthcare available to everyone. A
Walgreens Boots Alliance (WBA) Q1 2023 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported first quarter 2023 earnings results today. Sales decreased 1.5% year-over-year to $33.4 billion. Net loss
WBA Stock: Should you invest in Walgreens Boots Alliance ahead of earnings?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been a key contributor to the COVID-19 vaccination campaign, supported by its extensive retail network.
CVS Health Corporation (CVS) Earnings: 3Q22 Key Numbers
CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results. Total revenues increased 10% year-over-year to $81.2 billion. Net loss attributable
Walgreens Boots Alliance (WBA) Q4 2022 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2022 earnings results today. Total sales amounted to $32.4 billion compared to $34.2 billion
Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's adjusted profit
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The
CVS Health (CVS) is a great stock to buy this year. Here’s why
CVS Health Corporation (NYSE: CVS), a diversified health services company, made an impressive start to the year after ending 2021 on a
CVS Health Earnings Q1 2022: Here are the key highlights from the results
CVS Health (NYSE: CVS) reported first quarter 2022 earnings results today. Total revenues for the quarter increased to $76.8 billion, up 11.2%
Key highlights from Walgreens Boots Alliance (WBA) Q2 2022 earnings results
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2022 earnings results today. Sales increased 3% year-over-year to $33.8 billion. Sales growth
Sigma Healthcare Ltd (SIG) Q4 2021 Earnings Call Transcript
Sigma Healthcare Ltd ( ?????? : SIG) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Vikesh Ramsunder -- Chief Executive Officer and
Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company's revenues